Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase

Journal of Chemical Information and Modeling

Volumn 52, Issue 10, 2012, Pages 2715-2729

  Li, Lin ^a   Li, Youyong ^a   Zhang, Liling ^a   Hou, Tingjun ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FREE ENERGY; HEALTH RISKS; MOLECULAR DYNAMICS; VIRUSES;

CONFORMATIONAL CHANGE; ENERGY DECOMPOSITION; ENERGY DECOMPOSITION ANALYSIS; MOLECULAR DYNAMICS SIMULATIONS; MOLECULAR MECHANISM; MOLECULAR SIMULATIONS; POLAR INTERACTIONS; THEORETICAL STRUCTURE;

BINDING ENERGY;

ANTIVIRUS AGENT; OSELTAMIVIR; SIALIDASE; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HUMAN; INFLUENZA VIRUS A H1N1; MUTATION; PROTEIN CONFORMATION; STRUCTURAL HOMOLOGY; THERMODYNAMICS;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; COMPUTER SIMULATION; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MODELS, MOLECULAR; MUTATION; NEURAMINIDASE; OSELTAMIVIR; PROTEIN CONFORMATION; STRUCTURAL HOMOLOGY, PROTEIN; THERMODYNAMICS; VIRAL PROTEINS;

EID: 84867759741     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci300375k     Document Type: Article

References (105)

1. Cheng, V. C. C.; To, K. K. W.; Tse, H.; Hung, I. F. N.; Yuen, K. Y. Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned? Clin. Microbiol. Rev. 2012, 25, 223-263
2. Garten, R. J.; Davis, C. T.; Russell, C. A.; Shu, B.; Lindstrom, S.; Balish, A.; Sessions, W. M.; Xu, X.; Skepner, E.; Deyde, V. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans Science 2009, 325, 197-201
3. Memorandums, M. L. A revision of the system of nomenclature for influenza viruses: a WHO memorandum Bull. W. H. O. 1980, 58, 585-591
4. Von Itzstein, M. The war against influenza: discovery and development of sialidase inhibitors Nat. Rev. Drug Discovery 2007, 6, 967-974
5. Xu, X.; Zhu, X.; Dwek, R. A.; Stevens, J.; Wilson, I. A. Structural characterization of the 1918 influenza virus H1N1 neuraminidase J. Virol. 2008, 82, 10493-10501
6. McKimm-Breschkin, J. L. Resistance of influenza viruses to neuraminidase inhibitors-a review Antiviral Res. 2000, 47, 1-17
7. Kobasa, D.; Kodihalli, S.; Luo, M.; Castrucci, M. R.; Donatelli, I.; Suzuki, Y.; Suzuki, T.; Kawaoka, Y. Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase J. Virol. 1999, 73, 6743-6751
8. Cheng, L. S.; Amaro, R. E.; Xu, D.; Li, W. W.; Arzberger, P. W.; McCammon, J. A. Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase J. Med. Chem. 2008, 51, 3878-3894
9. Sung, J. C.; Wynsberghe, A. W. V.; Amaro, R. E.; Li, W. W.; McCammon, J. A. Role of secondary sialic acid binding sites in influenza N1 neuraminidase J. Am. Chem. Soc. 2010, 132, 2883-2885
10. Amaro, R. E.; Swift, R. V.; Votapka, L.; Li, W. W.; Walker, R. C.; Bush, R. M. Mechanism of 150-cavity formation in influenza neuraminidase Nat. Commun. 2011, 2, 388
11. Kolocouris, N.; Zoidis, G.; Foscolos, G. B.; Fytas, G.; Prathalingham, S. R.; Kelly, J. M.; Naesens, L.; De Clercq, E. Design and synthesis of bioactive adamantane spiro heterocycles Bioorg. Med. Chem. Lett. 2007, 17, 4358-4362
12. Lew, W.; Chen, X.; Kim, C. U. Discovery and Development of GS 4104 (oseltamivir) An Orally Active Influenza Neuraminidase Inhibitor Curr. Med. Chem. 2000, 7, 663-672
13. Dunn, C. J.; Goa, K. L. Zanamivir: a review of its use in influenza Drugs 1999, 58, 761-784
14. Liu, H.; Yao, X.; Wang, C.; Han, J. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase Mol. Pharmaceutics 2010, 7, 894-904
15. Wang, Y. T.; Chan, C.; Su, Z. Y.; Chen, C. L. Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A (H1N1) influenza neuraminidase Biophys. Chem. 2010, 147, 74-80
16. Yen, H. L.; Ilyushina, N. A.; Salomon, R.; Hoffmann, E.; Webster, R. G.; Govorkova, E. A. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo J. Virol. 2007, 81, 12418-12426
17. de Jong, M. D.; Thanh, T. T.; Khanh, T. H.; Hien, V. M.; Smith, G. J. D.; Chau, N. V.; Cam, B. V.; Qui, P. T.; Ha, D. Q.; Guan, Y. Oseltamivir resistance during treatment of influenza A (H5N1) infection N. Engl. J. Med. 2005, 353, 2667-2672
18. Lackenby, A.; Hungnes, O.; Dudman, S. G.; Meijer, A.; Paget, W. J.; Hay, A. J.; Zambon, M. C. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe Eurosurveillance 2008, 13, 1-2
19. Gubareva, L. V.; Kaiser, L.; Matrosovich, M. N.; Soo-Hoo, Y.; Hayden, F. G. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir J. Infect. Dis. 2001, 183, 523-531
20. Kiso, M.; Mitamura, K.; Sakai-Tagawa, Y.; Shiraishi, K.; Kawakami, C.; Kimura, K.; Hayden, F. G.; Sugaya, N.; Kawaoka, Y. Resistant influenza A viruses in children treated with oseltamivir: descriptive study Lancet 2004, 364, 759-765
21. Le, Q. M.; Kiso, M.; Someya, K.; Sakai, Y. T.; Nguyen, T. H.; Nguyen, K. H. L.; Pham, N. D.; Ngyen, H. H.; Yamada, S.; Muramoto, Y. Avian flu: isolation of drug-resistant H5N1 virus Nature 2005, 437, 1108-1108
22. Collins, P. J.; Haire, L. F.; Lin, Y. P.; Liu, J.; Russell, R. J.; Walker, P. A.; Skehel, J. J.; Martin, S. R.; Hay, A. J.; Gamblin, S. J. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants Nature 2008, 453, 1258-1261
23. Pan, D.; Sun, H.; Bai, C.; Shen, Y.; Jin, N.; Liu, H.; Yao, X. Prediction of zanamivir efficiency over the possible 2009 Influenza A (H1N1) mutants by multiple molecular dynamics simulations and free energy calculations J. Mol. Model. 2011, 17, 2465-2473
24. Malaisree, M.; Rungrotmongkol, T.; Decha, P.; Intharathep, P.; Aruksakunwong, O.; Hannongbua, S. Understanding of known drug-arget interactions in the catalytic pocket of neuraminidase subtype N1 Proteins 2008, 71, 1908-1918
25. Malaisree, M.; Rungrotmongkol, T.; Nunthaboot, N.; Aruksakunwong, O.; Intharathep, P.; Decha, P.; Sompornpisut, P.; Hannongbua, S. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation Amino Acids 2009, 37, 725-732
26. Rungrotmongkol, T.; Udommaneethanakit, T.; Malaisree, M.; Nunthaboot, N.; Intharathep, P.; Sompornpisut, P.; Hannongbua, S. How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants? Biophys. Chem. 2009, 145, 29-36
27. Masukawa, K. M.; Kollman, P. A.; Kuntz, I. D. Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations J. Med. Chem. 2003, 46, 5628-5637
28. Lawrenz, M.; Baron, R.; McCammon, J. A. Independent-trajectories thermodynamic-integration free-energy changes for biomolecular systems: Determinants of H5N1 avian influenza virus neuraminidase inhibition by peramivir J. Chem. Theory Comput. 2009, 5, 1106-1116
29. Shu, M.; Lin, Z.; Zhang, Y.; Wu, Y.; Mei, H.; Jiang, Y. Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus J. Mol. Model. 2011, 17, 587-592
30. Landon, M. R.; Amaro, R. E.; Baron, R.; Ngan, C. H.; Ozonoff, D.; Andrew McCammon, J.; Vajda, S. Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble Chem. Biol. Drug Des. 2008, 71, 106-116
31. Kar, P.; Knecht, V. Mutation-Induced Loop Opening and Energetics for Binding of Tamiflu to Influenza N8 Neuraminidase J. Phys. Chem. B. 2012, 116, 6137-6149
32. Zhang, J.; Hou, T.; Wang, W.; Liu, J. S. Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 1321-1326
33. Amaro, R. E.; Cheng, X.; Ivanov, I.; Xu, D.; McCammon, J. A. Characterizing loop dynamics and ligand recognition in human-and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations J. Am. Chem. Soc. 2009, 131, 4702-4709
34. Amaro, R. E.; Minh, D. D. L.; Cheng, L. S.; Lindstrom, W. M., Jr; Olson, A. J.; Lin, J. H.; Li, W. W.; McCammon, J. A. Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design J. Am. Chem. Soc. 2007, 129, 7764-7765
35. Rodríguez-Barrios, F.; Balzarini, J.; Gago, F. The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulations J. Am. Chem. Soc. 2005, 127, 7570-7578
36. Hou, T.; Yu, R. Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance J. Med. Chem. 2007, 50, 1177-1188
37. Hou, T.; McLaughlin, W. A.; Wang, W. Evaluating the potency of HIV-1 protease drugs to combat resistance Proteins: Struct., Funct., Bioinf. 2008, 71, 1163-1174
38. Chachra, R.; Rizzo, R. C. Origins of resistance conferred by the R292K neuraminidase mutation via molecular dynamics and free energy calculations J. Chem. Theory Comput. 2008, 4, 1526-1540
39. Barreca, M. L.; Lee, K. W.; Chimirri, A.; Briggs, J. M. Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance Biophys. J. 2003, 84, 1450-1463
40. Hou, T.; Zhang, W.; Wang, J.; Wang, W. Predicting drug resistance of the HIV-1 protease using molecular interaction energy components Proteins: Struct., Funct., Bioinf. 2009, 74, 837-846
41. Xue, W. W.; Qi, J.; Yang, Y.; Jin, X. J.; Liu, H. X.; Yao, X. J. Understanding the effect of drug-resistant mutations of HIV-1 intasome on raltegravir action through molecular modeling study Mol. Biosyst. 2012, 8, 2135-2144
42. Xue, W. W.; Pan, D. B.; Yang, Y.; Liu, H. X.; Yao, X. J. Molecular modeling study on the resistance mechanism of HCV NS3/4A serine protease mutants R155K, A156V and D168A to TMC435 Antiviral Res. 2012, 93, 126-137
43. Pan, D. B.; Sun, H. J.; Shen, Y. L.; Liu, H. X.; Yao, X. J. Exploring the molecular basis of dsRNA recognition by NS1 protein of influenza A virus using molecular dynamics simulation and free energy calculation Antiviral Res. 2011, 92, 424-433
44. Woods, C. J.; Malaisree, M.; Pattarapongdilok, N.; Sompornpisut, P.; Hannongbua, S.; Mulholland, A. J. Long Time Scale GPU Dynamics Reveal the Mechanism of Drug Resistance of the Dual Mutant I223R/H275Y Neuraminidase from H1N1-2009 Influenza Virus Biochemistry 2012, 51, 4364-4375
45. Karthick, V.; Shanthi, V.; Rajasekaran, R.; Ramanathan, K. Exploring the Cause of Oseltamivir Resistance Against Mutant H274Y Neuraminidase by Molecular Simulation Approach J. Phys. Chem. B 2012, 1-13
46. Udommaneethanakit, T.; Rungrotmongkol, T.; Bren, U.; Frecer, V.; Stanislav, M. Dynamic behavior of avian influenza a virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues J. Chem. Inf. Model. 2009, 49, 2323-2332
47. Wang, N. X.; Zheng, J. J. Computational studies of H5N1 influenza virus resistance to oseltamivir Protein Sci. 2009, 18, 707-715
48. Li, M. S.; Nguyen, T. T.; Mai, B. K. Study of Tamiflu Sensitivity to Variants of A/H5N1 Virus Using Different Force Fields J. Chem. Inf. Model. 2011, 51, 2266-2276
49. Hitaoka, S.; Harada, M.; Yoshida, T.; Chuman, H. Correlation Analyses on Binding Affinity of Sialic Acid Analogues with Influenza Virus Neuraminidase-1 Using ab Initio MO Calculations on Their Complex Structures J. Chem. Inf. Model. 2010, 50, 1796-1805
50. Park, J. W.; Jo, W. H. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir J. Chem. Inf. Model. 2009, 49, 2735-2741
51. Rungrotmongkol, T.; Malaisree, M.; Nunthaboot, N.; Sompornpisut, P.; Hannongbua, S. Molecular prediction of oseltamivir efficiency against probable influenza A (H1N1-2009) mutants: molecular modeling approach Amino Acids 2010, 39, 393-398
52. Boivin, G.; Goyette, N. Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors Antiviral Res. 2002, 54, 143-147
53. Zürcher, T.; Yates, P. J.; Daly, J.; Sahasrabudhe, A.; Walters, M.; Dash, L.; Tisdale, M.; McKimm-Breschkin, J. L. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro J. Antimicrob. Chemother. 2006, 58, 723-732
54. Mishin, V. P.; Hayden, F. G.; Gubareva, L. V. Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors Antimicrob. Agents Chemother. 2005, 49, 4515-4520
55. Arias, C. F.; Escalera-Zamudio, M.; de los Dolores Soto-Del Río, M.; Georgina Cobián-Güemes, A.; Isa, P.; López, S. Molecular anatomy of 2009 influenza virus A (H1N1) Arch. Med. Res. 2009, 40, 643-654
56. McKimm-Breschkin, J. L.; Selleck, P. W.; Usman, T. B.; Johnson, M. A. Reduced sensitivity of influenza A (H5N1) to oseltamivir Emerg. Infect. Dis. 2007, 13, 1354
57. Pruitt, K. D.; Tatusova, T.; Maglott, D. R. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins Nucleic Acids Res. 2007, 35, D61-D65
58. Discovery Studio 2.5 Guide; Accelrys Inc.: San Diego, CA, 2009. http://www.accelrys.com (accessed Sept. 2012).
59. Case, D. A.; Cheatham, T. E., III; Darden, T.; Gohlke, H.; Luo, R.; Merz, K. M., Jr; Onufriev, A.; Simmerling, C.; Wang, B.; Woods, R. J. The Amber biomolecular simulation programs J. Comput. Chem. 2005, 26, 1668-1688
60. Dolinsky, T. J.; Czodrowski, P.; Li, H.; Nielsen, J. E.; Jensen, J. H.; Klebe, G.; Baker, N. A. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations Nucleic Acids Res. 2007, 35, W522-W525
61. Li, H.; Robertson, A. D.; Jensen, J. H. Very fast empirical prediction and rationalization of protein pKa values Proteins 2005, 61, 704-721
62. Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M. C.; Xiong, G.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations J. Comput. Chem. 2003, 24, 1999-2012
63. Wang, J.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and testing of a general amber force field J. Comput. Chem. 2004, 25, 1157-1174
64. Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M. Gaussian 03, revision C. 02; Gaussian: Wallingford, CT, 2004.
65. Bayly, C. I.; Cieplak, P.; Cornell, W.; Kollman, P. A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model J. Phys. Chem. 1993, 97, 10269-10280
66. Åqvist, J. Ion Water Interaction Potentials Derived from Free-Energy Perturbation Simulations J. Phys. Chem. 1990, 94, 8021-8024
67. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of simple potential functions for simulating liquid water J. Chem. Phys. 1983, 79, 926
68. Berendsen, H. J. C.; Postma, J. P. M.; Van Gunsteren, W. F.; DiNola, A.; Haak, J. R. Molecular dynamics with coupling to an external bath J. Chem. Phys. 1984, 81, 3684
69. Essmann, U.; Perera, L.; Berkowitz, M. L.; Darden, T.; Lee, H.; Pedersen, L. G. A smooth particle mesh Ewald method J. Chem. Phys. 1995, 103, 8577
70. Ryckaert, J. P.; Ciccotti, G.; Berendsen, H. J. C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes J. Comput. Phys. 1977, 23, 327-341
71. Miyamoto, S.; Kollman, P. A. Absolute and relative binding free energy calculations of the interaction of biotin and its analogs with streptavidin using molecular dynamics/free energy perturbation approaches Proteins 1993, 16, 226-245
72. Luzhkov, V. B.; Almlöf, M.; Nervall, M.; Åqvist, J. Computational study of the binding affinity and selectivity of the bacterial ammonium transporter AmtB Biochemistry 2006, 45, 10807-10814
73. Zwanzig, R. W. High-Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases J. Chem. Phys. 1954, 22, 1420-1426
74. Jorgensen, W. L.; Thomas, L. L. Perspective on Free-Energy Perturbation Calculations for Chemical Equilibria J. Chem. Theory Comput. 2008, 4, 869-876
75. Gohlke, H.; Klebe, G. Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors Angew. Chem., Int. Ed. 2002, 41, 2644-2676
76. Kirkwood, J. G. Statistical mechanics of fluid mixtures J. Chem. Phys. 1935, 3, 300
77. Srinivasan, J.; Cheatham, T. E., III; Cieplak, P.; Kollman, P. A.; David, A. Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate-DNA helices J. Am. Chem. Soc. 1998, 120, 9401-9409
78. Kollman, P. A.; Massova, I.; Reyes, C.; Kuhn, B.; Huo, S.; Chong, L.; Lee, M.; Lee, T.; Duan, Y.; Wang, W. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models Acc. Chem. Res. 2000, 33, 889-897
79. Wang, J. M.; Hou, T. J.; Xu, X. J. Recent advances in free energy calculations with a combination of molecular mechanics and continuum models Curr. Comput.-Aided Drug Des. 2006, 2, 287-306
80. Homeyer, N.; Gohlke, H. Free Energy Calculations by the Molecular Mechanics Poisson-Boltzmann Surface Area Method Mol. Inf. 2012, 31, 114-122
81. Hou, T. J.; Wang, J.; Li, Y. Y.; Wang, W. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking J. Comput. Chem. 2011, 32, 866-877
82. Hou, T. J.; Wang, J. M.; Li, Y. Y.; Wang, W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations J. Chem. Inf. Model. 2011, 51, 69-82
83. Perdih, A.; Bren, U.; Solmajer, T. Binding free energy calculations of N-sulphonyl-glutamic acid inhibitors of MurD ligase J. Mol. Model. 2009, 15, 983-996
84. Lee, F. S.; Chu, Z. T.; Bolger, M. B.; Warshel, A. Calculations of antibody-antigen interactions: microscopic and semi-microscopic evaluation of the free energies of binding of phosphorylcholine analogs to McPC603 Protein Eng. 1992, 5, 215-228
85. Bren, U.; Lah, J.; Bren, M.; Martinek, V.; Florian, J. DNA duplex stability: the role of preorganized electrostatics J. Phys. Chem. B 2010, 114, 2876-2885
86. Hou, T. J.; Zhang, W.; Xu, X. J. Binding affinities for a series of selective inhibitors of gelatinase-A using molecular dynamics with a linear interaction energy approach J. Phys. Chem. B 2001, 105, 5304-5315
87. Bonnet, P.; Bryce, R. A. Molecular dynamics and free energy analysis of neuraminidase-ligand interactions Protein Sci. 2004, 13, 946-957
88. Luo, R.; David, L.; Gilson, M. K. Accelerated Poisson-Boltzmann calculations for static and dynamic systems J. Comput. Chem. 2002, 23, 1244-1253
89. Jedrzejas, M. J.; Singh, S.; Brouillette, W. J.; Laver, W. G.; Air, G. M.; Luo, M. Structures of aromatic inhibitors of influenza virus neuraminidase Biochemistry 1995, 34, 3144-3151
90. von Itzstein, M.; Dyason, J. C.; Oliver, S. W.; White, H. F.; Wu, W. Y.; Kok, G. B.; Pegg, M. S. A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs J. Med. Chem. 1996, 39, 388-391
91. Smith, B. J.; Colman, P. M.; Von Itzstein, M.; Danylec, B.; Varghese, J. N. Analysis of inhibitor binding in influenza virus neuraminidase Protein Sci. 2001, 10, 689-696
92. Bren, U.; Martínek, V.; Florián, J. Decomposition of the solvation free energies of deoxyribonucleoside triphosphates using the free energy perturbation method J. Phys. Chem. B 2006, 110, 12782-12788
93. Bren, M.; Florián, J.; Mavri, J.; Bren, U. Do all pieces make a whole? Thiele cumulants and the free energy decomposition Theor. Chem. Acc. 2007, 117, 535-540
94. Hou, T.; Li, N.; Li, Y.; Wang, W. Characterization of Domain-peptide Interaction Interface: Prediction of SH3 Domain-Mediated Protein-protein Interaction Network in Yeast by Generic Structure-Based Models J. Proteome Res. 2012, 11, 2982
95. Gohlke, H.; Kiel, C.; Case, D. A. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes J. Mol. Biol. 2003, 330, 891-913
96. Hou, T.; Zhang, W.; Case, D. A.; Wang, W. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain J. Mol. Biol. 2008, 376, 1201-1214
97. Hou, T.; Xu, Z.; Zhang, W.; McLaughlin, W. A.; Case, D. A.; Xu, Y.; Wang, W. Characterization of Domain-Peptide Interaction Interface Mol. Cell. Proteomics 2009, 8, 639-649
98. Hou, T. J.; Li, Y. Y.; Wang, W. Prediction of peptides binding to the PKA RII alpha subunit using a hierarchical strategy Bioinformatics 2011, 27, 1814-1821
99. Onufriev, A.; Bashford, D.; David, A. Modification of the generalized Born model suitable for macromolecules J. Phys. Chem. B 2000, 104, 3712-3720
100. Colman, P. M.; Varghese, J. N.; Laver, W. G. Structure of the catalytic and antigenic sites in influenza virus neuraminidase Nature 1983, 303, 41-44
101. Russell, R. J.; Haire, L. F.; Stevens, D. J.; Collins, P. J.; Lin, Y. P.; Blackburn, G. M.; Hay, A. J.; Gamblin, S. J.; Skehel, J. J. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design Nature 2006, 443, 45-49
102. Le, L.; Lee, E. H.; Hardy, D. J.; Truong, T. N.; Schulten, K. Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases Plos Comput. Biol. 2010, 6, e1000939
103. Moscona, A. Oseltamivir resistance-disabling our influenza defenses N. Engl. J. Med. 2005, 353, 2633-2636
104. Rungrotmongkol, T.; Intharathep, P.; Malaisree, M.; Nunthaboot, N.; Kaiyawet, N.; Sompornpisut, P.; Payungporn, S.; Poovorawan, Y.; Hannongbua, S. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus Biochem. Biophys. Res. Commun. 2009, 385, 390-394
105. Pizzorno, A.; Bouhy, X.; Abed, Y.; Boivin, G. Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors J. Infect. Dis. 2011, 203, 25-31